A new pill developed by the drug company Merck may soon help millions of people lower their cholesterol and reduce the risk of heart attacks and...
Vous n'êtes pas connecté
Maroc - The New York Times - NYTimes.com Home Page (U.S.) - 08/Nov 22:57
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk.
A new pill developed by the drug company Merck may soon help millions of people lower their cholesterol and reduce the risk of heart attacks and...
THURSDAY, Nov. 13, 2025 — A new investigational pill from Merck could change how millions of people treat high cholesterol and help prevent...
THURSDAY, Nov. 13, 2025 — A new investigational pill from Merck could change how millions of people treat high cholesterol and help prevent...
A new oral PCSK9 inhibitor, enlicitide, offers a daily pill option for lowering LDL-C, a key cardiovascular disease risk factor. A clinical trial...
Colchicine, an inexpensive drug used to treat gout, could cut heart attacks and strokes in people with cardiovascular disease. ......
A DRUG prescribed to thousands of Brits a could reduce the risk of a heart attack or stroke, according to a new study. Researchers found colchicine -...
A DRUG prescribed to thousands of Brits a could reduce the risk of a heart attack or stroke, according to a new study. Researchers found colchicine -...
When this happens, the inflammation of arteries makes them less flexible, while increasing their risk of rupturing, which results in heart attacks....
A cheap gout medication, colchicine, shows significant promise in preventing heart attacks and strokes for individuals with existing heart disease. A...
A cheap gout medication, colchicine, shows significant promise in preventing heart attacks and strokes for individuals with existing heart disease. A...